Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 2 4Phase 1/2 2Phase NA 1Phase 3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 170Neoplasms 129Prostatic Neoplasms 92Lung Neoplasms 82Colorectal Neoplasms 80Pancreatic Neoplasms 38Leiomyoma 37Carcinoma, Hepatocellular 36Lymphoma, Follicular 35Carcinoma, Non-Small-Cell Lung 31Neoplasm Metastasis 27Skin Neoplasms 26Liver Neoplasms 26Colonic Neoplasms 26Uterine Cervical Neoplasms 25Multiple Myeloma 23Glioblastoma 22Head and Neck Neoplasms 21Barrett Esophagus 21Polycystic Ovary Syndrome 19Brain Neoplasms 18Urinary Bladder Neoplasms 17Polyps 16Ovarian Neoplasms 15Esophageal Neoplasms 15Stomach Neoplasms 14Squamous Cell Carcinoma of Head and Neck 14Rectal Neoplasms 14Carcinoma, Squamous Cell 14Carcinoma, Basal Cell 14

Interventions

pegylated granulocyte colony-stimulating factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × INDUSTRY × Advanced Pancreatic Cancer × Clear all
NCT04239001 2020-01-23

Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of Albumin Paclitaxel Combined With S-1 in the First-line Treatment of Advanced Pancreatic Cancer

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Phase NA Unknown
20 enrolled
Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡